A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
Recruiting · NCT07380412 · Interventional (participants receive a specific treatment) · Lead sponsor: Outliers, Inc.
View the official record on ClinicalTrials.gov →Interventions studied
PlaceboStasis Daytime and Nighttime
What this trial is about
This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.
Who can take part
Age range
18 Years to 55 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Aged 18-55 years
- Currently prescribed stimulant medication for ADHD
- Experiencing: sleep difficulty, irritability, anxiety, brain fog
- Stable medication dose ≥3 months
- Healthy with no uncontrolled chronic conditions
- Stable on supplements ≥3 months if applicable
- US resident
- Willing to maintain current habits
Exclusion criteria
- Chronic conditions (e.g. cancer, mental illness)
- Use of psychiatric medications besides stimulants
- Pregnancy, breastfeeding, thyroid, liver, kidney conditions
- Recent smokers or heavy alcohol use
- Night shift workers
- Participation in other clinical trials
- Allergies to product ingredients
Where it is running
1 location listed across 1 US state.
- Citruslabs - Las Vegas, Nevada, United States